This study offers an insight into the pharmaceutical industry of Ethiopia, where preference for generic, prescription drugs is growing. There is information on recent reforms introduced by the government (like tax benefits for in-country production, national strategy, and plan of action for pharmaceutical manufacturing development, growth and transformation plan, and so on), key participants in the market, population and disease statistics, and so on. The study also describes the opportunities and constraints in the market and revenue forecasts for the total market from 2011–2020. Primary research interviews with industry stakeholders and secondary research through in-house Frost & Sullivan database and news reports were undertaken.
Electronic Access - Site License Fulfilled By Publisher
Electronic Access - Global site License Fulfilled By Publisher